(Q33343710)

English

Thiazolidinediones increase the number of platelets in immune thrombocytopenic purpura mice via inhibition of phagocytic activity of the reticulo-endothelial system

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Thiazolidinediones increase the number of platelets in immune thrombocytopenic purpura mice via inhibition of phagocytic activity of the reticulo-endothelial system (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

thrombocytopenia

1 reference

based on heuristic

inferred from title

Immune thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

author name string

Keizo Kasono

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jyunji Nishida

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroyuki Tamemoto

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kazuko Fudaka

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kazuyuki Namai

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroshi Kajio

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kuroki Masatoshi

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yasunori Kanazawa

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masanobu Kawakami

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2037-2052

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Prognosis of Children with Virus-Associated Hemophagocytic Syndrome and Malignant Histiocytosis: Correlation with Levels of Serum Interleukin-1 and Tumor Necrosis Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Hypercytokinemia in hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

A nuclear receptor to prevent colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

PPARgamma: observations in the hematopoietic system

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901950-1

7 January 2021

Identifiers

10.1016/S0024-3205(02)01950-1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33343710&oldid=1588181608"